The finding that median HOMA2 insulin sensitivity and median levels of most plasma metabolites associated with diabetes risk were not significantly different in the obese HIV-infected subjects versus HIV-negative controls was unexpected in light of epidemiologic studies showing significantly higher rates of incident diabetes in HIV-infected patients compared with non-infected persons.2,3 We attribute this to 3 factors. The gene discussed is INS; the disease is diabetes mellitus.